Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Week 27 of “Mai Mai” Pathology Reading Notes | Overview of Immunohistochemical Markers for Lymphoid Neoplasms Diagnosis (Part 3)

Continue reading
06 2 月

Gathering Cases, Fostering Innovation // Rare and Complex Case Collection in Progress…

Continue reading
06 2 月

Maixin Biotech Holds Strategic Communication Meeting to Fully Explain and Interpret Its Five-Year Development Plan

Continue reading
06 2 月

IHC Master’s Diary: Antigen Retrieval – Heat-Induced Epitope Retrieval

Continue reading
06 2 月

Ten Years of Honing a Sword, One Moment to Test Its Edge: The 2018 USCAP Debut of Maxin’s Fully Automated Pathology Staining System on the International Stage

Continue reading
06 2 月

IHC Detection of MMR Protein Series Tweets – Interpretation of MMR Protein Detection Results

Continue reading
06 2 月

Sorting Out Antibodies Related to Histone H3.3

Continue reading
06 2 月

MaiXin Announcement

Continue reading
06 2 月

MaiXin 25th Anniversary Employee Special: Hi, 25-Year-Old You and Me!

Continue reading
06 2 月

Role of HE4 Expression in Different Tumors

Continue reading
  • «
  • ‹
  • 45
  • 46
  • 47
  • 48
  • 49
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar